201 related articles for article (PubMed ID: 27626171)
1. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells.
Liu Z; Chu S; Yao S; Li Y; Fan S; Sun X; Su L; Liu X
Oncotarget; 2016 Oct; 7(42):68303-68313. PubMed ID: 27626171
[TBL] [Abstract][Full Text] [Related]
2. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis.
Loreth D; Schuette M; Zinke J; Mohme M; Piffko A; Schneegans S; Stadler J; Janning M; Loges S; Joosse SA; Lamszus K; Westphal M; Müller V; Glatzel M; Matschke J; Gebhardt C; Schneider SW; Belczacka I; Volkmer B; Greinert R; Yaspo ML; Harter PN; Pantel K; Wikman H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209696
[TBL] [Abstract][Full Text] [Related]
3. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells.
Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L
Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041
[TBL] [Abstract][Full Text] [Related]
4. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.
Shi X; Leng L; Wang T; Wang W; Du X; Li J; McDonald C; Chen Z; Murphy JW; Lolis E; Noble P; Knudson W; Bucala R
Immunity; 2006 Oct; 25(4):595-606. PubMed ID: 17045821
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-342 targets Cofilin 1 to suppress the growth, migration and invasion of human breast cancer cells.
Liu C; Xing H; Luo X; Wang Y
Arch Biochem Biophys; 2020 Jul; 687():108385. PubMed ID: 32335050
[TBL] [Abstract][Full Text] [Related]
6. CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells.
Metodieva G; Nogueira-de-Souza NC; Greenwood C; Al-Janabi K; Leng L; Bucala R; Metodiev MV
Neoplasia; 2013 Jun; 15(6):660-8. PubMed ID: 23730214
[TBL] [Abstract][Full Text] [Related]
7. CD74: a potential novel target for triple-negative breast cancer.
Tian B; Zhang Y; Li N; Liu X; Dong J
Tumour Biol; 2012 Dec; 33(6):2273-7. PubMed ID: 22935920
[TBL] [Abstract][Full Text] [Related]
8. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
9. The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.
Wu Q; Jiang Y; Cui S; Wang Y; Wu X
Oncol Rep; 2016 May; 35(5):2743-54. PubMed ID: 26936386
[TBL] [Abstract][Full Text] [Related]
10. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
11. CD44 acts through RhoA to regulate YAP signaling.
Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
[TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
13. c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.
Gordin M; Tesio M; Cohen S; Gore Y; Lantner F; Leng L; Bucala R; Shachar I
J Immunol; 2010 Aug; 185(4):2020-31. PubMed ID: 20639480
[TBL] [Abstract][Full Text] [Related]
14. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy.
Clark AJ; Petty HR
Sci Rep; 2016 Jun; 6():27039. PubMed ID: 27247112
[TBL] [Abstract][Full Text] [Related]
15. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
[TBL] [Abstract][Full Text] [Related]
16. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
17. Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB.
Kim JG; Choi KC; Hong CW; Park HS; Choi EK; Kim YS; Park JB
Free Radic Biol Med; 2017 Nov; 112():69-83. PubMed ID: 28712859
[TBL] [Abstract][Full Text] [Related]
18. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer.
Greenwood C; Metodieva G; Al-Janabi K; Lausen B; Alldridge L; Leng L; Bucala R; Fernandez N; Metodiev MV
J Proteomics; 2012 Jun; 75(10):3031-40. PubMed ID: 22178447
[TBL] [Abstract][Full Text] [Related]
19. Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis.
Manupati K; Yeeravalli R; Kaushik K; Singh D; Mehra B; Gangane N; Gupta A; Goswami K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166228. PubMed ID: 34311079
[TBL] [Abstract][Full Text] [Related]
20. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway.
Wang LH; Xiang J; Yan M; Zhang Y; Zhao Y; Yue CF; Xu J; Zheng FM; Chen JN; Kang Z; Chen TS; Xing D; Liu Q
Cancer Res; 2010 Nov; 70(22):9118-28. PubMed ID: 21045147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
